SELLAS Life Sciences Group, Inc. SLS
Set alert
8.55 USD 0.00 0.00%
At close
8.75 +0.20 +2.34%
Pre-market · Nov 3, 9:11 AM ET
Day range unavailable
1.39 52-week range 15.88
- YTD
- +126.79%
- 1 year
- +377.65%
- Open
- —
- Prev close
- 8.55
- Mkt cap
- 1.73B
- Vol
- 0
- Avg vol
- 6.79M
- EPS
- -0.21
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -85.50
- Beta
- 2.70
- Short ratio
- 10.31
- Inst. own
- 37.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 18, 2026
- 50-d avg
- 12.16
- 200-d avg
- 8.57
- 1y target
- 32.50
5D chart
Signals (106)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:50 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 3:50 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 3:45 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 3:00 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 2:55 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 2:25 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 2:00 PM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 1:50 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 1:05 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 20 hours ago |
| RSI: Oversold | Nov 2, 12:10 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 12:00 PM | 21 hours ago |
| RSI: Oversold | Nov 2, 11:55 AM | 21 hours ago |
| RSI: Oversold | Nov 2, 11:10 AM | 22 hours ago |
| RSI: Oversold | Nov 2, 10:55 AM | 22 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 22 hours ago |
Newest 20 of 106.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 32.50 +280.1% upside
Now 8.55
- Target (low)
- 30.00
- Target (mean)
- 32.50
- Target (high)
- 35.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.05 | -0.05 – -0.05 | -0.06 | +16.7% | 0 | 0.0% | 1 |
| Next quarter | -0.05 | -0.05 – -0.05 | -0.05 | 0.0% | 0 | 0.0% | 1 |
| Current year | -0.20 | -0.20 – -0.20 | -0.25 | +20.0% | 0 | 0.0% | 1 |
| Next year | -0.10 | -0.20 – 0.00 | -0.20 | +50.0% | 53.09M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 12, 2026 | Maxim Group | Maintained | Buy | Buy |
| Jul 16, 2025 | Maxim Group | Maintained | Buy | Buy |
| Nov 22, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 7, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 15, 2022 | Alliance Global Partners | Maintained | — | Buy |
| Jun 28, 2022 | Cantor Fitzgerald | Maintained | — | Overweight |
| Jul 21, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Nov 15, 2019 | Maxim Group | Upgrade | Hold | Buy |
| Apr 8, 2019 | Alliance Global Partners | Initiated | — | Buy |
| Nov 1, 2018 | Oppenheimer | Initiated | — | Outperform |
| Jul 20, 2018 | Maxim Group | Maintained | Buy | Buy |
| Apr 2, 2018 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 19, 2018 | Maxim Group | Upgrade | Hold | Buy |